Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
December 21 2020 - 4:01PM
Business Wire
– Webcast Available Through Gilead Corporate
Website –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel
O’Day, Gilead’s Chairman and Chief Executive Officer, will provide
an overview of the company at the 39th Annual J.P. Morgan
Healthcare Conference on Monday, January 11 at 12:40 p.m. Pacific
Time.
The live webcast can be accessed at the company’s Investors page
at http://investors.gilead.com. Please connect to the company’s
website at least 15 minutes prior to the start of the presentation
to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information about Gilead, please visit
the company’s website at www.gilead.com, follow Gilead on Twitter
(@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5
or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201221005099/en/
Monica Tellado, Investors (650) 522-5132
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024